DILATATION INTRAHEPATIC DUCT ACQUIRED

This adverse event was reported 292 times

These drugs are most commonly taken by patients reporting DILATATION INTRAHEPATIC DUCT ACQUIRED:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 51
1 OMEPRAZOLE 46
2 ALLOPURINOL 44
3 ONDANSETRON HYDROCHLORIDE 44
4 KETAMINE HYDROCHLORIDE 42
5 VORICONAZOLE 42
6 VORICONAZOLE INJECTION 42
7 MORPHINE 41
8 PANTOPRAZOLE 38
9 CYCLOSPORINE 37
See all common drugs associated with DILATATION INTRAHEPATIC DUCT ACQUIRED

DILATATION INTRAHEPATIC DUCT ACQUIRED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DENOSUMAB-BMWO 1 0.0303
1 ETOPOSIDE PHOSPHATE 20 0.0122
2 KETAMINE HYDROCHLORIDE 42 0.0082
3 CASPOFUNGIN ACETATE 11 0.0069
4 ACYCLOVIR SODIUM 5 0.0040
5 ESTRADIOL VALERATE 2 0.0026
6 CARBAMIDE PEROXIDE 1 0.0023
7 FOSFOMYCIN TROMETHAMINE 1 0.0016
8 BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE 1 0.0016
9 I. V. FAT EMULSION 1 0.0014
See all drugs enriched for association with DILATATION INTRAHEPATIC DUCT ACQUIRED